Jane Koh
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver physiology and pathology
- Epidemiology top 5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 12
- Oncology 6
- Pancreatic and Hepatic Oncology Research 2
- Cancer Treatment and Pharmacology 2
- Co-authors
- Winnie Yeo (27 shared papers)Frankie Mo (21 shared papers)Tony Mok (12 shared papers)Stephen L. Chan (14 shared papers)Anthony T.�C. Chan (14 shared papers)Paul B.S. Lai (10 shared papers)Philip J. Johnson (8 shared papers)Simon C.H. Yu (14 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Cancer Management and Research (2 papers)BMC Cancer (2 papers)Annals of Oncology (2 papers)The Oncologist (1 paper)
- Partner nations
- Hong KongChinaUnited Kingdom
In The Last Decade
Jane Koh
30 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 89
- Hepatology 660
- Epidemiology 448
- Oncology 339
- Cancer Research 169
- Pathology and Forensic Medicine 166
Countries citing papers authored by Jane Koh
This map shows the geographic impact of Jane Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Koh more than expected).
Fields of papers citing papers by Jane Koh
This network shows the impact of papers produced by Jane Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Koh. The network helps show where Jane Koh may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Koh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 485 | |
| 2 | 2008 | 253 | |
| 3 | 2009 | 182 | |
| 4 | 2008 | 160 | |
| 5 | 2015 | 105 | |
| 6 | 2006 | 98 | |
| 7 | 2008 | 72 | |
| 8 | 2007 | 52 | |
| 9 | 2005 | 44 | |
| 10 | 2017 | 41 | |
| 11 | 2005 | 34 | |
| 12 | 2019 | 32 | |
| 13 | 2015 | 28 | |
| 14 | 2017 | 26 | |
| 15 | 2017 | 24 | |
| 16 | 2020 | 17 | |
| 17 | 2015 | 13 | |
| 18 | 2018 | 13 | |
| 19 | 2004 | 11 | |
| 20 | 2004 | 10 |
About Jane Koh
Jane Koh is a scholar working on Hepatology, Oncology, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Hepatitis B Virus Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Treatment and Pharmacology (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Hepatology (660 citations), Epidemiology (448 citations), Oncology (339 citations), Cancer Research (169 citations) and Pathology and Forensic Medicine (166 citations). Jane Koh has collaborated with scholars based in Hong Kong, China and United Kingdom. Frequent co-authors include Winnie Yeo, Frankie Mo, Tony Mok, Stephen L. Chan, Anthony T.�C. Chan, Paul B.S. Lai, Philip J. Johnson, Simon C.H. Yu, Benny Zee and Brigette Ma. Their work appears in journals such as Journal of Clinical Oncology, Cancer Management and Research, BMC Cancer, Annals of Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.